Safety assessment of MEFAS: an innovative hybrid salt of mefloquine and artesunate for malaria treatment

References

• ANVISA, 2013. Guia para a condução de estudos não clínicos de toxicologia e segurança farmacológica necessários ao desenvolvimento de medicamentos. Brasília: ANVISA.
   Google Scholar
• Ashley, E.A., et al., 2014. Spread of artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine, 371 (5), 411–423.
   PubMed Web of Science ®Google Scholar
• Brasil, 2007. Ministério da Saúde. Biblioteca Virtual em Saúde. Secretaria de Vigilância em Saúde. Coordenação geral de desenvolvimento da epidemiologia em serviços. Brasília, Ministério da Saúde. Guia de Vigilância em saúde.1 ed 775.
   Google Scholar
• Camargo, E.P., 2003. Malária, maleita, paludismo. Ciência e Cultura, 55 (1), 26–29.
   Google Scholar
• Chinedu, E., Arome, D., and Ameh, F.S., 2013. A new method for determining acute toxicity in animal models. Toxicology International, 20 (3), 224.
   PubMedGoogle Scholar
• Croft, A.M. and Herxheimer, A., 2002. Tolerability of antimalaria drugs. Clinical Infectious Diseases, 34 (9), 1278–1278.
   PubMed Web of Science ®Google Scholar
• Cunningham, M.J., 2000. Genomics and proteomics: the new millennium of drug discovery and development. Journal of Pharmacological and Toxicological Methods, 44 (1), 291–300.
   PubMed Web of Science ®Google Scholar
• Dondorp, A.M., et al., 2009. Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine, 361 (5), 455–467.
   PubMed Web of Science ®Google Scholar
• Dondorp, A.M., et al., 2011. The threat of artemisinin-resistant malaria. The New England Journal of Medicine, 365 (12), 1073–1075.
   PubMed Web of Science ®Google Scholar
• Dorato, M.A. and Buckley, L.A., 2006. Toxicology in the drug discovery and development process. Current Protocols in Pharmacology, 32 (1), 10–13.
   Google Scholar
• Dow, G., et al., 2006. Mefloquine induces dose-related neurological effects in a rat model. Antimicrobial Agents and Chemotherapy, 50 (3), 1045–1053.
   PubMed Web of Science ®Google Scholar
• Gonzáles, F.H.D. and Silva, S.C., 2003. Introdução à bioquímica clínica veterinária. 1 ed. Porto Alegre, Brazil: UFRGS, 270.
   Google Scholar
• Guo, Z., 2016. Artemisinin anti-malarial drugs in China. Acta Pharmaceutica Sinica B, 6 (2), 115–124.
   PubMed Web of Science ®Google Scholar
• Hu, Y.Q., et al., 2017. Quinoline hybrids and their antiplasmodial and antimalarial activities. European Journal of Medicinal Chemistry, 139, 22–47.
   PubMed Web of Science ®Google Scholar
• Kremsner, P.G. and Krishna, S., 2004. Antimalarial combinations. Lancet (London, England)), 364 (9430), 285–294.
   PubMed Web of Science ®Google Scholar
• Krishna, S., Uhlemann, A.C., and Haynes, R.K., 2004. Artemisinins: mechanisms of action and potential for resistance. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, 7 (4–5), 233–244.
   PubMed Web of Science ®Google Scholar
• Li, Q., et al., 2007. Toxicity evaluation of artesunate and artelinate in Plasmodium berghei-infected and uninfected rats. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101 (2), 104–112.
   PubMed Web of Science ®Google Scholar
• Lombard, M.C., et al., 2011. Synthesis, in vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids. Bioorganic & Medicinal Chemistry Letters, 21 (6), 1683–1686.
   PubMed Web of Science ®Google Scholar
• Majori, G., 2004. Combined antimalarial therapy using artemisinin. Parassitologia, 46 (1–2), 85–87.
   PubMedGoogle Scholar
• Mbengue, A., et al., 2015. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature, 520 (7549), 683.
   PubMed Web of Science ®Google Scholar
• Meshnick, S.R., Taylor, T.E., and Kamchonwongpaisan, S., 1996. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiological Reviews, 60 (2), 301–315.
   PubMedGoogle Scholar
• Mishra, M., et al., 2017. Comprehensive review on various strategies for antimalarial drug discovery. European Journal of Medicinal Chemistry, 125, 1300–1320.
   PubMed Web of Science ®Google Scholar
• Na-Bangchang, K., et al., 2013. Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity. Malaria Journal, 12 (1), 263.
   PubMed Web of Science ®Google Scholar
• Nevin, R.L., 2014. Idiosyncratic quinoline central nervous system toxicity: historical insights into the chronic neurological sequelae of mefloquine. International Journal for Parasitology: Drugs and Drug Resistance, 4 (2), 118–125.
   PubMed Web of Science ®Google Scholar
• PAHO, 2016. Report on the situation of Malaria in the Americas, 2014. Washington, DC: PAHO, 42.
   Google Scholar
• Park, B.K., et al., 2002. Safety assessment of peroxide antimalarials: clinical and chemical perspectives. British Journal of Clinical Pharmacology, 46 (6), 521–529.
   Web of Science ®Google Scholar
• Pohlit, A., et al., 2013. Amazonian plant natural products: perspectives for discovery of new antimalarial drug leads. Molecules, 18 (8), 9219–9240.
   PubMed Web of Science ®Google Scholar
• Price, R., et al., 1999. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. The American Journal of Tropical Medicine and Hygiene, 60 (4), 547–555.
   PubMed Web of Science ®Google Scholar
• Quitério, G.C.M., 2006. Produção de artemisinina por Artemisia annua L. sob influência de Micorriza arbuscular. 48 f. Dissertation (Master of Dregree) – Instituto Agronômico, Campinas.
   Google Scholar
• Ribeiro, I.R. and Olliaro, P., 1998. Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Medecine Tropicale: revue du Corps de Sante Colonial, 58 (3), 50–53.
   PubMedGoogle Scholar
• Silva, T.B., et al., 2016. Design, synthesis and anti-P. falciparum activity of pyrazolopyridine–sulfonamide derivatives. Bioorganic & Medicinal Chemistry, 24 (18), 4492–4498.
   PubMed Web of Science ®Google Scholar
• Timbrell, J.A., 2009. Principles of biochemistry toxicology. 4th ed. Nova Iorque, Brazil: Editora Informa Heathcare, 12–14.
   Google Scholar
• Tracy, J.W. and Webster, L. T., 2005. Fármacos usados na quimioterapia das infecções por protozoários: malária. In: L.B. Laurence, J.S. Lazo, and K.L. Parker, eds. Goodman & Gilman: as bases farmacológicas da terapêutica. 11 ed. Nova Iorque, Brazil: Editora McGraw Hill, 803–822.
   Google Scholar
• Varotti de Pilla, F., et al., 2008. Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate. Antimicrobial Agents and Chemotherapy, 52 (11), 3868–3874.
   PubMed Web of Science ®Google Scholar
• Wells, T.N., Van Huijsduijnen, R.H., and Van Voorhis, W.C., 2015. Malaria medicines: a glass half full? Nature Reviews Drug Discovery, 14 (6), 424.
   PubMed Web of Science ®Google Scholar
• White, N.J., 1998. Preventing antimalarial drug resistance through combinations. Drug Resistance Updates, 1 (1), 3–9.
   PubMed Web of Science ®Google Scholar
• White, N.J. and Olliaro, P.L., 1996. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitology Today, 12 (10), 399–401.
   PubMedGoogle Scholar
• WHO, 2006. Guidelines for the treatment of malaria. Geneva, Switzerland: World Health Organization.
   Google Scholar
• WHO, 2014. World malaria report. Geneva, Switzerland: World Health Organization. Available from: http://www.who.int/malaria/publications/world_malaria_report_2014/en/ [Accessed 25April 2018].
   Google Scholar